|Articles|December 9, 2022
Inside Bioprocessing: Microbial bioproduction
Author(s)Thermo Fisher Scientific
The animal origin-free (AOF) trend in bioprocessing has taken a while to reach microbial bioproduction. In this podcast, we explore the reasons behind this and delve into how AOF products are impacting the future of biopharmaceutical manufacturing. We also discuss the first chemically defined microbial medium—the Gibco™ Bacto™ CD Supreme Fermentation Production Medium (FPM). Hydrolysate-free and AOF, this dry powder medium was specially designed to support high-cell-density cultures of E. Coli. Listen to bioprocessing experts and discover more.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network
3
Women in STEM: Early Phase Drug Development
4
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
5